Active Clinical Trials
AT-101 - Oral pan-Bcl-2 inhibitor – in Phase IIb clinical trials
Ascenta posts information for all ongoing clinical trials to the National Institutes of Health's (NIH) clinicaltrials.gov website.
To learn more about Ascenta clinical trials for AT-101 please visit http://www.clinicaltrials.gov/ct2/results?term=AT-101.
AT-406 – Oral multi-IAP Inhibitor – in Phase I clinical trials
Ascenta posts information for all ongoing clinical trials to the National Institutes of Health's (NIH) clinicaltrials.gov website.
To learn more about Ascenta clinical trials for AT-406 please visit http://www.clinicaltrial.gov/ct2/show/NCT01078649?term=at-406&rank=1.